A three-year-old child presents to the emergency department after ingesting a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues, including the brain. Physical examination reveals a heart rate of 100/minute, blood pressure of 110/60 mm Hg, and a respiratory rate of 20/minute. In this case of poisoning, which of the following is true?
What is the primary treatment for carbon monoxide poisoning?
In the management of toxicity caused by ingestion of methanol, which one of the following statements is most accurate?
Which of the following drugs is known to cause chronic active hepatitis?
Hepatic granulomas are seen with which of the following medications?
Which of the following predominantly cause sensory neuropathy?
High doses of lignocaine produce which of the following effects?
In which of the following poisonings is dimercaprol (BAL) contraindicated?
Which of the following is an oral complication of Cyclosporin?
Which of the following drugs does NOT cause acute kidney injury?
Explanation: ### Explanation The core concept in this question is **Ion Trapping**, which is governed by the Henderson-Hasselbalch principle. **1. Why Option A is Correct:** The drug is described as a **weak base**. In pharmacology, "like dissolves like." A weak base remains non-ionized (lipid-soluble) in an alkaline medium and becomes **ionized (water-soluble)** in an acidic medium. By administering **Ammonium Chloride (NH₄Cl)**, the urine is acidified. This causes the weak base antihistamine to become ionized within the renal tubules. Once ionized, the drug cannot diffuse back across the lipid membrane into the blood and is "trapped" in the urine, thereby accelerating its excretion. **2. Why the Other Options are Incorrect:** * **Option B:** Alkalinizing the urine with Sodium Bicarbonate (NaHCO₃) would keep a weak base in its non-ionized, lipid-soluble form, promoting its reabsorption into the bloodstream rather than excretion. (Note: NaHCO₃ is used for weak acid poisoning, like aspirin). * **Option C:** The stomach has a very low pH (acidic), while blood is slightly alkaline (pH 7.4). A weak base will be **more ionized in the acidic environment of the stomach** and less ionized in the blood. * **Option D:** Even for weak bases, the **small intestine** is the primary site of absorption due to its massive surface area and high vascularity compared to the stomach. **3. High-Yield NEET-PG Pearls:** * **Acidic Drugs (e.g., Aspirin, Barbiturates):** Excreted faster by **alkalinizing** the urine with NaHCO₃. * **Basic Drugs (e.g., Amphetamines, Antihistamines, Morphine):** Excreted faster by **acidifying** the urine with NH₄Cl or Vitamin C. * **Ion Trapping Rule:** Only the **non-ionized** form of a drug can cross lipid membranes (BBB, placenta, GI tract). The **ionized** form is water-soluble and excreted by the kidneys.
Explanation: **Explanation:** **1. Why 100% Oxygen is the Correct Answer:** Carbon monoxide (CO) has an affinity for hemoglobin that is **200–250 times greater** than that of oxygen. When CO binds to hemoglobin, it forms **carboxyhemoglobin (COHb)**, which shifts the oxygen-dissociation curve to the **left**, preventing the release of oxygen to tissues and causing cellular hypoxia. The primary treatment is **100% Oxygen** (normobaric) via a non-rebreather mask. Oxygen acts as a competitive antagonist; by increasing the partial pressure of oxygen in the blood, it displaces CO from hemoglobin. * **Half-life reduction:** On room air, the half-life of COHb is ~4–5 hours. With 100% oxygen, it reduces to ~60–90 minutes. In severe cases (e.g., COHb >25%, pregnancy, or neurological symptoms), **Hyperbaric Oxygen (HBO)** is used to further reduce the half-life to ~20 minutes. **2. Why Other Options are Incorrect:** * **B. Methylene Blue:** This is the specific antidote for **Methemoglobinemia**. It acts as a reducing agent to convert ferric iron ($Fe^{3+}$) back to the functional ferrous state ($Fe^{2+}$). * **A. Ascorbic Acid:** While it can be used as an adjunct in mild methemoglobinemia, it has no role in displacing CO from hemoglobin. **3. Clinical Pearls for NEET-PG:** * **Cherry-red skin/mucosa:** A classic but rare physical finding in CO poisoning. * **Pulse Oximetry Pitfall:** Standard pulse oximeters cannot distinguish between oxyhemoglobin and carboxyhemoglobin, often giving **falsely normal $SpO_2$ readings**. * **Diagnosis:** Confirmed via arterial blood gas (ABG) with **co-oximetry** to measure COHb levels. * **CT Brain:** May show bilateral necrosis of the **globus pallidus** in severe toxicity.
Explanation: ### Explanation **1. Why Option C is Correct:** Methanol itself is relatively non-toxic; however, it is metabolized by the enzyme **Alcohol Dehydrogenase (ADH)** into **formaldehyde**, which is then converted by aldehyde dehydrogenase into **formic acid**. Formic acid is the primary toxin responsible for metabolic acidosis and retinal damage (blindness) [1, 2]. **Ethanol** has a much higher affinity (approx. 10–20 times) for ADH than methanol. By acting as a competitive inhibitor, ethanol "occupies" the enzyme, preventing the conversion of methanol into its toxic metabolites. This allows methanol to be excreted unchanged by the kidneys or removed via dialysis [2]. **2. Why Other Options are Incorrect:** * **Option A:** **Disulfiram** inhibits aldehyde dehydrogenase. In methanol poisoning, this would lead to an accumulation of formaldehyde, worsening the toxicity. Disulfiram is used in chronic alcoholism to create an aversive reaction, not for acute poisoning [2]. * **Option B:** **Naltrexone** is an opioid receptor antagonist used to reduce cravings in alcohol dependence; it has no role in the metabolic management of acute alcohol poisoning. * **Option D:** Methanol is a small, water-soluble molecule with a low volume of distribution. Therefore, **hemodialysis** is highly effective and is a mainstay of treatment for severe poisoning (serum levels >50 mg/dL or severe acidosis). **3. NEET-PG High-Yield Pearls:** * **Fomepizole:** The preferred antidote over ethanol because it is a potent ADH inhibitor that does not cause CNS depression or hypoglycemia [2]. * **Cofactor Therapy:** **Folate (Leucovorin)** is administered to enhance the breakdown of formic acid into CO₂ and water. * **Classic Presentation:** "Snowstorm vision" or blurred vision, high anion gap metabolic acidosis (HAGMA), and an increased osmolar gap.
Explanation: **Explanation:** **Methyldopa** is a classic cause of **drug-induced chronic active hepatitis** [1]. The underlying mechanism is an immune-mediated (idiosyncratic) reaction. It can trigger the production of autoantibodies (similar to autoimmune hepatitis), leading to hepatocellular necrosis and inflammation that mimics chronic viral hepatitis. If the drug is not discontinued, it can progress to cirrhosis. **Analysis of Incorrect Options:** * **Oestrogen:** Primarily associated with **cholestatic jaundice** and an increased risk of hepatic adenomas or gallstones, rather than chronic active hepatitis. * **Erythromycin:** Specifically the estolate salt is a well-known cause of **acute cholestatic hepatitis**, characterized by jaundice, fever, and abdominal pain, usually resolving upon discontinuation. * **Tetracycline:** Causes **microvesicular steatosis** (fatty liver). This is a dose-dependent toxicity, often seen when high doses are given intravenously, particularly in pregnant women. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs causing Chronic Hepatitis:** Nitrofurantoin, Isoniazid (INH), and Dantrolene. * **Methyldopa Side Effects:** Apart from hepatitis, it is famous for causing a **Positive Direct Coombs Test** (hemolytic anemia) and hyperprolactinemia [1]. * **Drug of Choice:** Despite these risks, Methyldopa remains a preferred drug for managing **hypertension in pregnancy** (along with Labetalol and Hydralazine). * **Key Distinction:** Always distinguish between *cholestatic* (Erythromycin, OCPs) vs. *hepatocellular/active hepatitis* (Methyldopa, INH) patterns of injury in exam questions.
Explanation: **Explanation:** **Correct Option: C (Sulfonamides)** Hepatic granulomas are a form of drug-induced liver injury (DILI) characterized by organized collections of macrophages (epithelioid cells). **Sulfonamides** are a classic cause of granulomatous hepatitis, often presenting as a hypersensitivity reaction. The mechanism involves a delayed-type hypersensitivity (Type IV) response to the drug or its metabolites. Other drugs frequently associated with hepatic granulomas include Allopurinol, Hydralazine, Quinidine, and Phenytoin. **Analysis of Incorrect Options:** * **A. Halothane:** Typically causes **massive hepatic necrosis** (centrilobular necrosis) rather than granulomas. This is often mediated by the formation of trifluoroacetylated liver proteins which trigger an immune response ("Halothane Hepatitis"). * **B. Chlorpromazine:** This is the prototype drug for causing **intrahepatic cholestasis** (bland cholestasis). It leads to "canalicular plugging" and jaundice, but not typically granuloma formation. * **C. Methyldopa:** Primarily associated with **chronic active hepatitis-like** pictures or autoimmune-mediated liver injury. It can also cause focal necrosis but is not a primary cause of granulomas. **NEET-PG High-Yield Pearls:** * **Granulomatous Hepatitis Mnemonic:** "S-H-A-P-E" (Sulfonamides, Hydralazine, Allopurinol, Phenytoin, Ethambutol). * **Centrilobular (Zone 3) Necrosis:** Seen with Paracetamol (Acetaminophen) toxicity, Halothane, and Carbon tetrachloride ($CCl_4$). * **Microvesicular Steatosis:** Associated with Sodium Valproate, Tetracyclines (especially in pregnancy), and Salicylates (Reye’s Syndrome). * **Macrovesicular Steatosis:** Most commonly caused by Alcohol and Methotrexate.
Explanation: **Explanation:** The correct answer is **Cisplatin**. This platinum-based chemotherapeutic agent is notorious for causing a dose-dependent, **predominantly sensory peripheral neuropathy**. **1. Why Cisplatin is correct:** Cisplatin accumulates in the **dorsal root ganglia (DRG)**, which lack a robust blood-nerve barrier. It causes DNA damage and oxidative stress in the sensory neurons, leading to a "dying-back" axonal degeneration. Patients typically present with a "glove-and-stocking" distribution of sensory loss, paresthesia, and loss of vibratory sense. Unlike many other drugs, it rarely affects motor fibers. **2. Analysis of Incorrect Options:** * **Pyridoxine (Vitamin B6) excess:** While chronic high doses of Pyridoxine *can* cause a pure sensory neuropathy, it is less commonly tested in this context compared to Cisplatin. Furthermore, in the context of NEET-PG, Cisplatin is the classic pharmacological prototype for drug-induced sensory neuropathy. * **Diphtheria:** This causes a **mixed** neuropathy. The toxin typically leads to cranial nerve palsies (palatal paralysis) followed by a generalized sensorimotor polyneuropathy. * **Guillain-Barre Syndrome (GBS):** This is the classic example of an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It is characterized by **predominantly motor**, ascending paralysis. **Clinical Pearls for NEET-PG:** * **Other drugs causing Sensory Neuropathy:** Taxanes (Paclitaxel), Thalidomide, and Ethambutol. * **Drugs causing Motor Neuropathy:** Dapsone, Lead poisoning (wrist drop/foot drop), and Vincristine (though Vincristine is often mixed, motor involvement is prominent). * **Cisplatin Toxicity Triad:** Nephrotoxicity (prevented by Amifostine/hydration), Ototoxicity, and Peripheral Neuropathy.
Explanation: Lignocaine (Lidocaine) is an amide-linked local anesthetic that acts by blocking voltage-gated sodium channels. While it is used for local anesthesia and as a Class IB antiarrhythmic, high systemic concentrations lead to **Local Anesthetic Systemic Toxicity (LAST)**, affecting the Central Nervous System (CNS) and the Cardiovascular System (CVS). **Why "All of the above" is correct:** 1. **Convulsions (CNS Effects):** Lignocaine initially inhibits inhibitory cortical neurons, leading to excitatory symptoms like perioral numbness, tremors, and eventually **generalized tonic-clonic convulsions** [1, 2]. This is the most classic sign of lignocaine toxicity. 2. **Respiratory Depression:** As toxicity progresses, the drug causes global CNS depression. This leads to the suppression of the medullary respiratory center, resulting in respiratory arrest. 3. **Hypotension (CVS Effects):** Lignocaine has a direct negative inotropic effect (decreases myocardial contractility) and causes peripheral vasodilation. At very high doses, it also blocks cardiac sodium channels, leading to bradycardia, arrhythmias, and profound hypotension [1]. **Clinical Pearls for NEET-PG:** * **Order of Toxicity:** CNS symptoms (convulsions) typically appear *before* CVS collapse (hypotension/asystole) with lignocaine. This is in contrast to Bupivacaine, where CNS and CVS toxicity often occur simultaneously. * **Treatment of Choice:** For systemic toxicity (LAST), the specific antidote is **Intravenous Lipid Emulsion (ILE) 20%** [2]. * **Maximum Dose:** The maximum safe dose of lignocaine is **4.5 mg/kg** (plain) and **7 mg/kg** (with adrenaline). * **Metabolism:** It is metabolized in the liver; hence, toxicity is more common in patients with hepatic dysfunction or heart failure.
Explanation: **Explanation:** **Dimercaprol (British Anti-Lewisite or BAL)** is a chelating agent that contains sulfhydryl (-SH) groups which bind to heavy metals to form stable, non-toxic, soluble complexes excreted in the urine. **Why Cadmium is the Correct Answer:** Dimercaprol is strictly **contraindicated** in **Cadmium** poisoning. While BAL can chelate cadmium, the resulting **BAL-Cadmium complex is highly nephrotoxic**. This complex dissociates in the acidic environment of the renal tubules, releasing free cadmium which causes severe acute tubular necrosis and renal failure. For cadmium toxicity, calcium disodium EDTA or supportive care is preferred. **Analysis of Incorrect Options:** * **Arsenic:** BAL is the **drug of choice** for acute arsenic poisoning. It prevents the inhibition of the pyruvate dehydrogenase complex by arsenic. * **Lead:** BAL is used as an adjunct to EDTA in **Lead Encephalopathy** (severe lead poisoning) because it can cross the blood-brain barrier. * **Mercury:** BAL is effective in **Inorganic Mercury** poisoning. However, it is generally avoided in *organic* (methyl) mercury poisoning as it may redistribute mercury to the brain. (Note: In the context of this question, Cadmium is the absolute contraindication). **High-Yield Clinical Pearls for NEET-PG:** * **Route:** BAL is administered via **deep intramuscular (IM)** injection because it is dispensed in peanut oil (avoid in patients with peanut allergies). * **Side Effects:** It frequently causes a rise in blood pressure and tachycardia. * **Iron Interaction:** Do not use BAL during **Iron** therapy, as the BAL-Iron complex is also toxic. * **Water-soluble analogs:** Succimer (DMSA) and Unithiol (DMPS) are safer, oral alternatives to BAL with fewer side effects.
Explanation: **Explanation:** **Gingival hyperplasia** is a well-documented side effect of **Cyclosporine** [1], a calcineurin inhibitor used as an immunosuppressant in organ transplantation and autoimmune diseases. The mechanism involves the stimulation of gingival fibroblasts and an increase in the production of extracellular matrix (collagen), often exacerbated by poor oral hygiene. It typically manifests within 1–3 months of starting therapy. **Analysis of Options:** * **B & D (Leukoplakia and Squamous cell carcinoma):** While chronic immunosuppression increases the long-term risk of malignancies (like skin cancer or lymphomas) [3], they are not specific "oral complications" directly caused by the pharmacological action of Cyclosporine on oral tissues. * **A (Oral thrush):** Candidiasis is a common opportunistic infection in immunocompromised patients, but it is a secondary infection rather than a direct drug-induced structural change like hyperplasia. **High-Yield NEET-PG Pearls:** 1. **The "Triple Threat" of Gingival Hyperplasia:** Remember the three main classes of drugs causing this: * **Anticonvulsants:** Phenytoin (most common). * **Calcium Channel Blockers (CCBs):** Nifedipine (highest incidence), Amlodipine. * **Immunosuppressants:** Cyclosporine [1]. 2. **Cyclosporine Toxicity Profile:** Apart from gingival hyperplasia, it is notorious for **Nephrotoxicity** (most common), **Hepatotoxicity**, **Hirsutism**, and **Hypertension** [1], [3]. 3. **Tacrolimus:** Often preferred over Cyclosporine in clinical practice because it does **not** cause gingival hyperplasia or hirsutism [2].
Explanation: **Explanation:** The correct answer is **Amoxicillin**. While many drugs are nephrotoxic, Amoxicillin is generally considered safe for the kidneys. It is more commonly associated with **Type I hypersensitivity reactions** (rashes/anaphylaxis) rather than direct Acute Kidney Injury (AKI). Although it can rarely cause Acute Interstitial Nephritis (AIN), it does not cause direct tubular or vascular toxicity like the other options. **Analysis of Options:** * **Diclofenac (NSAIDs):** These inhibit COX enzymes, leading to decreased synthesis of **Prostaglandins (PGE2 and PGI2)**. Since prostaglandins are responsible for dilating the afferent arteriole, NSAIDs cause afferent vasoconstriction, reducing renal perfusion and causing pre-renal AKI. * **Amphotericin B:** This antifungal is notorious for causing **dose-dependent nephrotoxicity**. It binds to ergosterol in fungal membranes but also interacts with cholesterol in human renal tubular cells, leading to "punched-out" holes in the membranes, causing tubular damage and severe electrolyte wasting (Type 1 RTA). * **Aminoglycosides (e.g., Gentamicin):** These cause **Acute Tubular Necrosis (ATN)**. They are filtered by the glomerulus and then reabsorbed into the proximal convoluted tubule (PCT) cells, where they accumulate and cause oxidative stress and cell death. **High-Yield NEET-PG Pearls:** * **Triple Whammy:** The dangerous combination of **ACE inhibitors/ARBs + Diuretics + NSAIDs** significantly increases the risk of AKI. * **Aminoglycoside Toxicity:** Characterized by non-oliguric renal failure occurring 5–7 days after starting therapy. * **Drug of Choice for Amphotericin Nephrotoxicity:** Liposomal Amphotericin B is used to reduce renal side effects. * **Contrast-Induced Nephropathy:** Prevented primarily by adequate **saline hydration**.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free